Human CDKN3 Protein

<strong>Human CDKN3 Protein</strong>_x000D_ <strong>Catalog number:</strong> B2011915_x000D_ <strong>Lot number:</strong> Batch Dependent_x000D_ <strong>Expiration Date:</strong> Batch dependent_x000D_ <strong>Amount:</strong> 100 µg_x000D_ <strong>Molecular Weight or Concentration:</strong> 0.5 mg/mL_x000D_ <strong>Supplied as:</strong> Solution_x000D_ <strong>Applications:</strong> molecular tool for various biochemical applications_x000D_ <strong>Storage:</strong> -20 °C_x000D_ <strong>Keywords:</strong> KAP protein, CDI1 protein, CDKN 3 protein, CDKN3, CDKN-3, CDKN-3 protein, KAP1, Cyclin-dependent kinase inhibitor 3 protein, CDKN 3, CIP2 protein_x000D_ <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity &gt;18 MΩ-cm) and are filtered through 0.22 um._x000D_ _x000D_ <strong>References:</strong>_x000D_ 1: Zeisel S. Choline, Other Methyl-Donors and Epigenetics Nutrients. 2017 Apr 29;9(5):445._x000D_ 2: Zhou Z, Li Y, Hao H, Wang Y, Zhou Z, Wang Z, Chu X. Screening Hub Genes as Prognostic Biomarkers of Hepatocellular Carcinoma by Bioinformatics Analysis Cell Transplant. 2019 Dec;28(1_suppl):76S-86S._x000D_ 3: Jiang CH, Yuan X, Li JF, Xie YF, Zhang AZ, Wang XL, Yang L, Liu CX, Liang WH, Pang LJ, Zou H, Cui XB, Shen XH, Qi Y, Jiang JF, Gu WY, Li F, Hu JM. Bioinformatics-based screening of key genes for transformation of liver cirrhosis to hepatocellular carcinoma J Transl Med. 2020 Jan 30;18(1):40._x000D_ 4: Berumen J, Espinosa AM, Medina I. Targeting CDKN3 in cervical cancer Expert Opin Ther Targets. 2014 Oct;18(10):1149-62._x000D_ 5: Zhang LP, Li WJ, Zhu YF, Huang SY, Fang SY, Shen L, Gao YL. CDKN3 knockdown reduces cell proliferation, invasion and promotes apoptosis in human ovarian cancer Int J Clin Exp Pathol. 2015 May 1;8(5):4535-44. eCollection 2015._x000D_ 6: Cress WD, Yu P, Wu J. Expression and alternative splicing of the cyclin-dependent kinase inhibitor-3 gene in human cancer Int J Biochem Cell Biol. 2017 Oct;91(Pt B):98-101._x000D_ 7: Li WH, Zhang L, Wu YH. CDKN3 regulates cisplatin resistance to colorectal cancer through TIPE1 Eur Rev Med Pharmacol Sci. 2020 Apr;24(7):3614-3623._x000D_ 8: Fan C, Chen L, Huang Q, Shen T, Welsh EA, Teer JK, Cai J, Cress WD, Wu J. Overexpression of major CDKN3 transcripts is associated with poor survival in lung adenocarcinoma Br J Cancer. 2015 Dec 22;113(12):1735-43._x000D_ 9: Cen J, Liang Y, Huang Y, Pan Y, Shu G, Zheng Z, Liao X, Zhou M, Chen D, Fang Y, Chen W, Luo J, Zhang J. Circular RNA circSDHC serves as a sponge for miR-127-3p to promote the proliferation and metastasis of renal cell carcinoma via the CDKN3/E2F1 axis Mol Cancer. 2021 Jan 20;20(1):19._x000D_ <a href="https://pubmed.ncbi.nlm.nih.gov/24573179">10: Li T, Xue H, Guo Y, Guo K. CDKN3 is an independent prognostic factor and promotes ovarian carcinoma cell proliferation in ovarian cancer Oncol Rep. 2014 Apr;31(4):1825-31. </a>_x000D_ _x000D_ <strong>Products Related to Human CDKN3 Protein can be found at</strong> <a href="https://moleculardepot.com/product-category/Proteins/"> Proteins</a>